Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Kaufmann

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Investigative Radiology|June 24, 2005
Evaluation of the stereotactic 8G vacuum-assisted breast biopsy in the histologic evaluation of suspicious mammography findings (BI-RADS IV)Thomas Diebold, Tanja Hahn, Christine Solbach, et al.
Archives of Gynecology and Obstetrics|November 6, 2013
Breakthroughs in research and treatment of early breast cancer: an overview of the last three decadesManfred Kaufmann, Gunter von Minckwitz, Jonas Bergh, et al.
Breast Care (Basel, Switzerland)|May 24, 2012
Breast Cancer Proteomics - Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag TechnologyEugen Ruckhäberle, Thomas Karn, Lars Hanker, et al.
Breast Cancer Research : BCR|April 3, 2008
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breastGunter von Minckwitz, Hans-Peter Sinn, Günter Raab, et al.
Lancet (London, England)|August 9, 2005
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trialRaimund Jakesz, Walter Jonat, Michael Gnant, et al.
Journal of the National Cancer Institute|April 10, 2008
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio studyGunter von Minckwitz, Sherko Kümmel, Petra Vogel, et al.
Journal of the National Cancer Institute|April 10, 2008
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trialGunter von Minckwitz, Sherko Kümmel, Petra Vogel, et al.
Annals of Surgical Oncology|September 20, 2006
Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trialSibylle Loibl, Gunter von Minckwitz, Günther Raab, et al.
Breast Cancer Research : BCR|October 8, 2011
A clinically relevant gene signature in triple negative and basal-like breast cancerAchim Rody, Thomas Karn, Cornelia Liedtke, et al.
Breast Cancer Research and Treatment|October 13, 2006
The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugsPeter A Fasching, Gunter von Minckwitz, Thorsten Fischer, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Investigative Radiology|June 24, 2005
Evaluation of the stereotactic 8G vacuum-assisted breast biopsy in the histologic evaluation of suspicious mammography findings (BI-RADS IV)Thomas Diebold, Tanja Hahn, Christine Solbach, et al.
Archives of Gynecology and Obstetrics|November 6, 2013
Breakthroughs in research and treatment of early breast cancer: an overview of the last three decadesManfred Kaufmann, Gunter von Minckwitz, Jonas Bergh, et al.
Breast Care (Basel, Switzerland)|May 24, 2012
Breast Cancer Proteomics - Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag TechnologyEugen Ruckhäberle, Thomas Karn, Lars Hanker, et al.
Breast Cancer Research : BCR|April 3, 2008
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breastGunter von Minckwitz, Hans-Peter Sinn, Günter Raab, et al.
Lancet (London, England)|August 9, 2005
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trialRaimund Jakesz, Walter Jonat, Michael Gnant, et al.
Journal of the National Cancer Institute|April 10, 2008
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio studyGunter von Minckwitz, Sherko Kümmel, Petra Vogel, et al.
Journal of the National Cancer Institute|April 10, 2008
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trialGunter von Minckwitz, Sherko Kümmel, Petra Vogel, et al.
Annals of Surgical Oncology|September 20, 2006
Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trialSibylle Loibl, Gunter von Minckwitz, Günther Raab, et al.
Breast Cancer Research : BCR|October 8, 2011
A clinically relevant gene signature in triple negative and basal-like breast cancerAchim Rody, Thomas Karn, Cornelia Liedtke, et al.
Breast Cancer Research and Treatment|October 13, 2006
The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugsPeter A Fasching, Gunter von Minckwitz, Thorsten Fischer, et al.
Pageof 15